True identity by immunohistochemistry and molecular morphology of undifferentiated malignancies of the head and neck

Head and Neck

Volumn 31, Issue 7, 2009, Pages 949-961

  Carbone, Antonino ^a   Gloghini, Annunziata ^a   Rinaldo, Alessandra ^b   Devaney, Kenneth O ^c   Tubbs, Raymond ^d   Ferlito, Alfio ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c Allegiance Health ^*  (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Head and neck tumors; Immunohistochemistry; Molecular morphology; Prognosis; Undifferentiated malignancies

Indexed keywords

CYTOKERATIN; TUMOR MARKER; VIMENTIN;

ALGORITHM; ATYPICAL CARCINOID TUMOR; BASAL CELL CARCINOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SCREENING; CELL LINEAGE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EPITHELIUM CELL; EPITHELIUM TUMOR; HEAD AND NECK CARCINOMA; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOEPITHELIOMA; LYMPHOID CELL; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MEDICAL INFORMATION; MELANOCYTE; MELANOMA; MERKEL CELL TUMOR; MESENCHYME; MICROSCOPY; MORPHOLOGY; MUCOSAL MALIGNANT MELANOMA; NEUROENDOCRINE TUMOR; PARAGANGLIOMA; PATHOLOGIST; PLASMABLASTIC LYMPHOMA; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINONASAL NK T CELL LYMPHOMA; SMALL CELL NEUROENDOCRINE CARCINOMA; SMALL CELL SARCOMA; SPINDLE CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; TISSUE TYPES; TYPICAL CARCINOID; UNDIFFERENTIATED CARCINOMA;

CARCINOMA; DIAGNOSIS, DIFFERENTIAL; GENETIC TECHNIQUES; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY;

EID: 67650466938     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21080     Document Type: Review

References (71)

1. Bahrami A, Truong LD, Ro JY. Undifferentiated tumor: true identity by immunohistochemistry. Arch Pathol Lab Med 2008;132:326-348. (Pubitemid 351328809)
2. Wick MR. Immunohistochemical approaches to the diagnosis of undifferentiated malignant tumors. Ann Diagn Pathol 2008;12:72-84. (Pubitemid 350299213)
3. Bianchini WA, Altemani AM, Paschoal JR. Undifferentiated head and neck tumors: the contribution of immunohistochemical technique to differential diagnosis. Sao Paulo Med J 2003;121:244-247. (Pubitemid 38008711)
4. Gulley ML, Braziel RM, Halling KC, et al. Molecular Pathology Resource Committee, College of American Pathologists. Clinical laboratory reports in molecular pathology. Arch Pathol Lab Med 2007;131:852-863.
5. Banks ER, Frierson HF Jr, Mills SE, George E, Zarbo RJ, Swanson PE. Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immunohistochemical study of 40 cases. Am J Surg Pathol 1992;16:939-946.
6. Barnes L, Ferlito A, Altavilla G, MacMillan C, Rinaldo A, Doglioni C. Basaloid squamous cell carcinoma of the head and neck: clinicopathological features and differential diagnosis. Ann Otol Rhinol Laryngol 1996;105:75-82. (Pubitemid 26015373)
7. Altrabulsi B, Carrizo F, Luna MA. Spindle basaloid squamous carcinoma of the upper aerodigestive tract: immunohistochemical and clinicopathological study of three cases. Ann Diagn Pathol 2006;10:149-153. (Pubitemid 43765489)
8. Coletta RD, Almeida OP, Vargas PA. Cytokeratins 1, 7 and 14 immunoexpression are helpful in the diagnosis of basaloid squamous carcinoma. Histopathology 2006;48:773-774.
9. Serrano MF, El-Mofty SK, Gnepp DR, Lewis JS Jr. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck. Hum Pathol 2008;39:591-598.
10. Emanuel P, Wang B, Wu M, Burstein DE. p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. Mod Pathol 2005;18:645-650. (Pubitemid 40676375)
11. Soriano E, Faure C, Lantuejoul S, et al. Course and prognosis of basaloid squamous cell carcinoma of the head and neck: a case-control study of 62 patients. Eur J Cancer 2008;44:244-250.
12. Lewis JS, Ritter JH, El-Mofty S. Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder-p63, MOC-31, and TTF-1. Mod Pathol 2005;18:1471-1481. (Pubitemid 41509402)
13. Thompson LD, Wieneke JA, Miettinen M, Heffner DK. Spindle cell (sarcomatoid) carcinomas of the larynx: a clinicopathologic study of 187 cases. Am J Surg Pathol 2002;26:153-170. (Pubitemid 34127495)
14. Stelow EB, Mills SE. Squamous cell carcinoma variants of the upper aerodigestive tract. Am J Clin Pathol 2005;124 Suppl:S96-S109.
15. Bourne TD, Bellizzi AM, Stelow EB, et al. p63 Expression in olfactory neuroblastoma and other small cell tumors of the sinonasal tract. Am J Clin Pathol 2008;130:213-218.
16. Ferlito A, Devaney KO, Rinaldo A. Neuroendocrine neoplasms of the larynx: advances in identification, understanding and management. Oral Oncol 2006;42:770-778. (Pubitemid 44307769)
17. Lee DH, Cho HH, Cho YB. Typical carcinoid tumor of the nasal cavity. Auris Nasus Larynx 2007;34:537-539. (Pubitemid 47610808)
18. Babin E, Rouleau V, Vedrine PO, et al. Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. J Laryngol Otol 2006;120:289-297. (Pubitemid 46832964)
19. Lin IH, Hwang CF, Huang HY, Chien CY. Small cell carcinoma of the nasopharynx. Acta Otolaryngol 2007;127:206-208.
20. Wang CP, Hsieh CY, Chang YL, et al. Postirradiated neuroendocrine carcinoma of the sinonasal tract. Laryngoscope 2008;118:804-809. (Pubitemid 351631299)
21. Ferlito A, Rinaldo A. Primary and secondary small cell neuroendocrine carcinoma of the larynx: a review. Head Neck 2008;30:518-524. (Pubitemid 351578757)
22. Rinaldo A, Devaney KO, Ferlito A. Immunohistochemical studies in support of a diagnosis of small cell neuroendocrine carcinoma of the larynx. Acta Otolaryngol 2004;124:638-641. (Pubitemid 38858236)
23. Woodruff JM, Senie RT. Atypical carcinoid tumor of the larynx. A critical review of the literature. ORL J Otorhinolaryngol Relat Spec 1991;53:194-209.
24. Woodruff JM, Huvos AG, Erlandson RA, Shah JP, Gerold FP. Neuroendocrine carcinomas of the larynx. A study of two types, one of which mimics thyroid medullary carcinoma. Am J Surg Pathol 1985;9:771-790. (Pubitemid 16228096)
25. Miettinen M, Cupo W. Neural cell adhesion molecule distribution in soft tissue tumors. Hum Pathol 1993;24:62-66. (Pubitemid 23046674)
26. Moll R, Franke WW. Cytoskeletal differences between human neuroendocrine tumors: a cytoskeletal protein of molecular weight 46,000 distinguishes cutaneous from pulmonary neuroendocrine neoplasms. Differentiation 1985;30:165-175. (Pubitemid 16153852)
27. Mertz H, Vyberg M, Paulsen SM, Teglbjærg PS. Immunohistochemical detection of neuroendocrine markers in tumors of the lungs and gastrointestinal tract. Appl Immunohistochem 1998;6:175-180. (Pubitemid 28545920)
28. Shipley WR, Hammer RD, Lennington WJ, Macon WR. Paraffin immunohistochemical detection of CD56, a useful marker for neural cell adhesion molecule (NCAM), in normal and neoplastic fixed tissues. Appl Immunohistochem 1997;5:87-93. (Pubitemid 27237133)
29. Cerilli LA, Holst VA, Brandwein MS, Stoler MH, Mills SE. Sinonasal undifferentiated carcinoma: immunohistochemical profile and lack of EBV association. Am J Surg Pathol 2001;25:156-163. (Pubitemid 32167497)
30. Milroy CM, Ferlito A. Immunohistochemical markers in the diagnosis of neuroendocrine neoplasms of the head and neck. Ann Otol Rhinol Laryngol 1995;104:413-418.
31. Rossi S, Orvieto E, Furlanetto A, Laurino L, Ninfo V, Dei Tos AP. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Mod Pathol 2004;17:547-552. (Pubitemid 38868421)
32. Kumar S, Perlman E, Pack S, et al. Absence of EWS/FLI1 fusion in olfactory neuroblastomas indicates these tumors do not belong to the Ewing's sarcoma family. Hum Pathol 1999;30:1356-1360. (Pubitemid 29534299)
33. Gnepp DR. Small cell neuroendocrine carcinoma of the larynx. A critical review of the literature. ORL J Otorhinolaryngol Relat Spec 1991;53:210-219.
34. Soga J, Ferlito A, Rinaldo A. Endocrinocarcinomas (carcinoids and their variants) of the larynx: a comparative consideration with those of other sites. Oral Oncol 2004;40:668-672. (Pubitemid 38686902)
35. Ferlito A, Rinaldo A. Small cell neuroendocrine carcinoma of the larynx: a preventable and frustrating disease with a highly aggressive lethal behavior. ORL J Otorhinolaryngol Relat Spec 2003;65:131-133 (Editorial). (Pubitemid 37034381)
36. Pellitteri PK, Rinaldo A, Myssiorek D, et al. Paragangliomas of the head and neck. Oral Oncol 2004;40:563-575.
37. Rinaldo A, Ferlito A, Myssiorek D, Devaney KO. Which paragangliomas of the head and neck have a higher rate of malignancy? Oral Oncol 2004;40:458-460.
38. Suárez C, Rodrigo JP, Ferlito A, Devaney KO, Rinaldo A. Merkel cell carcinoma of the head and neck. Oral Oncol 2004;40:773-779. (Pubitemid 39061091)
39. Walsh NM. Primary neuroendocrine (Merkel cell) carcinoma of the skin: morphologic diversity and implications thereof. Hum Pathol 2001;32:680-689. (Pubitemid 32726892)
40. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 1995;8:384-388.
41. Jensen K, Kohler S, Rouse RV. Cytokeratin staining in Merkel cell carcinoma: an immunohistochemical study of cytokeratins 5/6, 7, 17, and 20. Appl Immunohistochem Mol Morphol 2000;8:310-315.
42. Su LD, Fullen DR, Lowe L, Uherova P, Schnitzer B, Valdez R. CD117 (KIT receptor) expression in Merkel cell carcinoma. Am J Dermatopathol 2002;24:289-293. (Pubitemid 34810303)
43. Nicholson SA, McDermott MB, Swanson PE, Wick MR. CD99 and cytokeratin-20 in small-cell and basaloid tumors of the skin. Appl Immunohistochem Mol Morphol 2000;8:37-41. (Pubitemid 30152352)
44. Brissett AE, Olsen KD, Kasperbauer JL, et al. Merkel cell carcinoma of the head and neck: a retrospective case series. Head Neck 2002;24:982-988. (Pubitemid 35217106)
45. Veness MJ, Palme CE, Morgan GJ. Merkel cell carcinoma: a review of management. Curr Opin Otolaryngol Head Neck Surg 2008;16:170-174. (Pubitemid 351354974)
46. Luaces Rey R, Fernández Alba J, Martín R, et al. Merkel cell carcinoma of the head and neck: report of seven cases. Med Oral Patol Oral Cir Bucal 2008;13:E390-E394.
47. Brandwein MS, Rothstein A, Lawson W, Bodian C, Urken ML. Sinonasal melanoma. A clinicopathologic study of 25 cases and literature meta-analysis. Arch Otolaryngol Head Neck Surg 1997;123:290-296.
48. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998;83:1664-1678. (Pubitemid 28465486)
49. Conley J, Pack GT. Melanoma of the mucous membranes of the head and neck. Arch Otolaryngol 1974;99:315-319.
50. Lentsch EJ, Myers JN. Melanoma of the head and neck: current concepts in diagnosis and management. Laryngoscope 2001;111:1209-1222. (Pubitemid 32625409)
51. Thompson LD, Wieneke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 2003;27:594-611. (Pubitemid 36514471)
52. Banerjee SS, Harris M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology 2000;36:387-402. (Pubitemid 30311621)
53. Granter SR, Weilbaecher KN, Quigley C, Fletcher CD, Fisher DE. Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation. Mod Pathol 2001;14:6-9.
54. Swanson PE, Wick MR. Clear cell sarcoma: an immunohistochemical analysis of six cases and comparison with other epithelioid neoplasms of soft tissue. Arch Pathol Lab Med 1989;113:55-60. (Pubitemid 19029751)
55. Fujimura Y, Ohno T, Siddique H, Lee L, Rao VN, Reddy ES. The EWSATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator. Oncogene 1996;12:159-167. (Pubitemid 26041252)
56. Medina JE, Ferlito A, Pellitteri PK, et al. Current management of mucosal melanoma of the head and neck. J Surg Oncol 2003;83:116-122. (Pubitemid 36667421)
57. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997;89:1413-1420. (Pubitemid 27080006)
58. Carbone A, Gaidano G, Gloghini A, Ferlito A, Rinaldo A, Stein H. AIDS-related plasmablastic lymphomas of the oral cavity and jaws: a diagnostic dilemma. Ann Otol Rhinol Laryngol 1999;108:95-99. (Pubitemid 29062127)
59. Higgins RA, Blankenship JE, Kinney MC. Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma. Arch Pathol Lab Med 2008;132:441-461. (Pubitemid 351328816)
60. Folk GS, Abbondanzo SL, Childers EL, Foss RD. Plasmablastic lymphoma: a clinicopathologic correlation. Ann Diagn Pathol 2006;10:8-12.
61. Cioc AM, Allen C, Kalmar JR, Suster S, Baiocchi R, Nuovo GJ. Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 2004;28:41-46. (Pubitemid 38031619)
62. Dong HY, Scadden DT, de Leval L, Tang Z, Isaacson PG, Harris NL. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol 2005;29:1633-1641. (Pubitemid 43754485)
63. Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol 2008;83:804-809.
64. Fellbaum C, Hansmann ML, Lennert K. Malignant lymphomas of the nasal cavity and paranasal sinuses. Virchows Arch A Pathol Anat 1989;414:399-405. (Pubitemid 19121761)
65. Campo E, Cardesa A, Alos L, et al. Non-Hodgkin's lymphomas of nasal cavity and paranasal sinuses. Am J Clin Pathol 1991;96:184-190.
66. Wong DS, Fuller LM, Butler JJ, Shullenberger CC. Extranodal non-Hodgkin's lymphomas of the head and neck. Am J Roentgenol Radium Ther Nucl Med 1975;123:471-481.
67. Ho FC, Choy D, Loke SL, et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract. Hum Pathol 1990;21:1041-1050.
68. Ng CS, Chan J, Lo S, Poon YF. Immunophenotypic analysis of non-Hodgkins's lymphomas in Chinese. Pathology 1986;18:419-425.
69. Chan JKC, Jafe ES, Ralfkiaer E. Extranodal NK/T-cell lymphoma, nasal type. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumours, pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. pp 204-207.
70. Carbone A, Gloghini A, Dotti G. EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist 2008;13:577-585. (Pubitemid 351872874)
71. Vidal RW, Devaney K, Ferlito A, Rinaldo A, Carbone A. Sinonasal malignant lymphomas: a distinct clinicopathological category. Ann Otol Rhinol Laryngol 1999;108: 411-419.